Back to News
research

Viatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
Viatris leadership outlined its long-term growth strategy during a March 2026 investor event, emphasizing a balanced portfolio across generics, established brands, and innovative medicines to drive sustainable revenue. CEO Scott Smith highlighted strategic priorities, including R&D investments in high-potential therapies and operational efficiency to offset pricing pressures in generics while expanding global market reach. Chief Commercial Officer Corinne Le Goff detailed plans to strengthen established brands through targeted marketing and partnerships, aiming to stabilize revenue amid patent expirations in key markets. CFO Theodora Mistras presented financial targets, projecting mid-single-digit revenue growth by 2030, supported by cost optimization and selective M&A to bolster the pipeline. Chief Strategy Officer Hemanth Varghese underscored geographic diversification, particularly in emerging markets, to mitigate risks and capture growth in underserved regions.
AI Audio Summary
0:00 / 0:00
Click to play
Untitled design (19).png
Quantum News · Media Library

SA Transcripts159.12K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Viatris Inc. (VTRS) Discusses Long-Term Growth Outlook and Portfolio Strategy Across Generics, Established Brands and Innovative Medicines March 19, 2026 10:00 AM EDT Company Participants William Szablewski - Head of Investor Relations & Capital MarketsScott Smith - CEO & DirectorPhilippe Martin - Chief R&D OfficerCorinne Le Goff - Chief Commercial OfficerHemanth Varghese - Chief Strategy OfficerTheodora Mistras - Chief Financial Officer Conference Call Participants Glen Santangelo - Barclays Bank PLC, Research DivisionLeszek Sulewski - Truist Securities, Inc., Research DivisionDavid Amsellem - Piper Sandler & Co., Research DivisionAshwani Verma - UBS Investment Bank, Research DivisionMatthew Dellatorre - Goldman Sachs Group, Inc., Research DivisionEthan Brown - JPMorgan Chase & Co, Research Division Presentation Operator Ladies and gentlemen, please welcome Head of Capital Markets Viatris, Bill Szablewski. William SzablewskiHead of Investor Relations & Capital Markets Good morning, everyone, and welcome to our Viatris Investor event. I'm Bill Szablewski, Head of Capital Markets and Investor Relations. It's great to see everyone here in a full room today. Before we begin, a few comments on our forward-looking and disclaimer. During today's discussion, we will be making forward-looking statements on a number of matters, including our strategic initiatives and priorities, pipeline, products and long-term financial targets. These statements are subject to risks and uncertainties that could cause future results to differ materially from today's presentation. Please refer to today's presentation and our SEC filings for more information. And with that, I'm pleased to introduce our leadership team. Starting with our CEO, Scott Smith; our Chief R&D Officer, Philippe Martin; our Chief Commercial Officer, Corinne Le Goff; our Chief Strategy Officer, Hemanth Varghese; and our Chief Financial Officer, Doretta Mistras. And with that, now I'd like to hand over today's presentation to Scott. Scott SmithCEO & Director Thank you, Bill. Thank you very much, and thank

Read Original

Tags

quantum-finance

Source Information

Source: Seeking Alpha